We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
86 hedge funds and large institutions have $28.3M invested in Atossa Therapeutics in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
59% more call options, than puts
Call options by funds: $165K | Put options by funds: $104K
26% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 23
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
0.14% more ownership
Funds ownership: 1.45% → 1.59% (+0.14%)
0% more funds holding
Funds holding: 86 → 86 (0)
32% less capital invested
Capital invested by funds: $41.6M → $28.3M (-$13.3M)
Holders
86
Holders Change
–
Holders Change %
0%
% of All Funds
1.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
29
Reduced
23
Closed
9
Calls
$165K
Puts
$104K
Net Calls
+$61K
Net Calls Change
-$774K
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.37M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$346K |
| 3 |
Renaissance Technologies
New York
|
+$322K |
| 4 |
JP Morgan Chase
New York
|
+$275K |
| 5 |
VF
Virtu Financial
New York
|
+$205K |
